In January 2018, the national centre of Azerbaijan became the 130th full member of the WHO Programme for International Drug Monitoring - and there is much progress to report.
WHO programme / 23 June 2022
Luxembourg joined the WHO Programme for International Drug Monitoring in 2020, and being part of the network has already supported the growth of the pharmacovigilance department.
WHO programme / 04 May 2022
Prof. Hervé Le Louët has resigned from his position as CEO of UMC due to family reasons. The recruitment process for next CEO starts immediately.
WHO programme / 30 March 2022
Recent additions mean the WHO Programme for International Drug Monitoring now stands at 143 full members and 28 associate members.
WHO programme / 30 March 2021
Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.